MedPath

Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients

Not Applicable
Completed
Conditions
Gait Disorders, Neurologic
Gait Disorder, Sensorimotor
Parkinson Disease
Interventions
Other: MIRT
Other: MIRT-AT
Registration Number
NCT03015714
Lead Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini
Brief Summary

Evaluation of the effectiveness of aquatic therapy for the treatment of freezing of gait in Parkinson's disease patients undergoing a multidisciplinary and intensive rehabilitation treatment.

Detailed Description

Freezing of gait (FoG) is an often dramatic, disabling episodic gait pattern that is common in Parkinson's disease (PD). FoG highly impairs mobility, causes falls, and reduces quality of life. Given the limited effectiveness of both the dopaminergic therapy and the deep brain stimulation on this symptom, it represents a challenge in the field of rehabilitation. In the last years, some studies described the effectiveness of aquatic therapy on balance dysfunction in patients with PD, correlating it to the safe conditions offered by the aquatic environment and to the physical properties of water. Nevertheless, the issues concerning the feasibility and the effectiveness of aquatic therapy for the treatment of FoG have never been addressed before. The aquatic environment may act on the sensorial peripheral receptors, thus widely stimulating the proprioceptive system. PD patients show an altered processing of the proprioceptive information that could potentially underline FoG. The investigators aim at investigating the effects of aquatic therapy for the treatment of FoG in PD patients undergoing a Multidisciplinary Intensive Rehabilitation Treatment (MIRT), whose effectiveness on several motor and functional parameters has been already demonstrated.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosis of PD according to Gelb et al;
  • Hoehn & Yahr (H&Y) stage 2.5-3;
  • Presence of FOG confirmed in the patient assessment prior to participation in the study;
  • Stable pharmacological treatment for the last 8 weeks and during the rehabilitation period;
  • Mini Mental State Examination (MMSE) ≥ 24;
Exclusion Criteria
  • Cardiac, pulmonary, vestibular and orthopedic diseases;
  • Urinary incontinence;
  • Severe dyskinesias;
  • Patients treated with deep brain stimulation;
  • Visual deficits;
  • Comorbilities other than PD determining reduction of motor autonomy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MIRTMIRTPatients in this group will undergo a 4-week Multidisciplinary Intensive Rehabilitation Treatment (MIRT).
MIRT-ATMIRT-ATPatients in this group will undergo a 4-week Multidisciplinary Intensive Rehabilitation Treatment associated with Aquatic Therapy (MIRT-AT).
Primary Outcome Measures
NameTimeMethod
Freezing of Gait Questionnaire (FOGQ)4 weeks

Assess FoG frequency, disturbances in gait and relationship to clinical features conceptually associated with gait and motor aspects.

Secondary Outcome Measures
NameTimeMethod
Six Minutes Walking Test (6MWT)4 weeks

Motor-functional test for gait endurance

Timed Up and Go Test (TUG)4 weeks

Motor-functional test for sit to stand, walking and turning evaluation

Unified Parkinson's Disease Rating Scale tot (UPDRS tot)4 weeks

Clinician-scored monitored patient's global evaluation.

Unified Parkinson's Disease Rating Scale Part III (UPDRS III)4 weeks

UPDRS subpart: clinician-scored monitored patient's motor evaluation

Unified Parkinson's Disease Rating Scale Part II (UPDRS II)4 weeks

UPDRS subart: clinician-scored monitored patient's activitied daily life evaluation

Berg Balance Scale (BBS)4 weeks

Motor-functional test for balance evaluation

Trial Locations

Locations (1)

"Moriggia-Pelascini" Hospital

🇮🇹

Gravedona Ed Uniti, Como, Italy

© Copyright 2025. All Rights Reserved by MedPath